Asosiy kontentga oʻtish
Maqola

Viral Regulation of Telomerase, Telomere Dysfunction, and Apoptotic Susceptibility in Infection and Pathogenesis

Usamah SayedFaculty of Medical Sciences, University of Isfahan, Isfahan, IranRavshan SultanovDepartment of Medical Fundamental Sciences, Termez University of Economics and Service, Termez, UzbekistanLeyla KhakimovaDepartment of Family and Preventive Medicine, Public Health, and Health Care Management, Faculty of Postgraduate Education, Samarkand State Medical University, Samarkand, UzbekistanAya Mohammed DhiaaRasim Mahdi SalihAl-Zahrawi University College, Karbala, IraqMohaned AdilPharmacy college, Al-Farahidi University, IraqSafa HussenCentre of Research Impact and Outcome, Chitkara University, Rajpura- 140417, Punjab, India
2026en
ABI

Annotatsiya

Viral infections reprogram telomerase activity and telomere homeostasis in a context dependent manner, influencing antiviral immunity, cellular survival, viral persistence, and malignant transformation. Telomerase suppression in antiviral lymphocytes may reduce proliferative capacity and increase apoptotic susceptibility, whereas telomerase activation in reservoir or transformed cells may promote latency, clonal expansion, and oncogenesis. Thus, evidence does not support a universal progression from viral infection to telomerase inhibition, telomere shortening, and apoptosis. The available evidence can instead be organized into a conceptual framework of three routes: acute loss of telomere-independent TERT functions, progressive telomere attrition after sustained telomerase impairment, or telomeric damage independent of telomerase inhibition. These routes are not equally validated, and evidence for the acute TERT-dependent route comes mainly from nonviral TERT-perturbation models. These mechanisms differ in timing and molecular requirements but may converge on deoxyribonucleic acid (DNA) damage, mitochondrial dysfunction, and apoptosis. In this review, we critically distinguish these pathways and assess the opposing therapeutic strategies of preserving telomerase in immune and regenerative cells while selectively inhibiting it in persistent or malignant cells.

Hali tarjima qilinmagan

Identifikatorlar

Iqtiboslar va manbalar